Publication | Closed Access
AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis
18
Citations
19
References
2023
Year
InflammationMolecular PharmacologyNari-29-an EpalrestatMolecular PhysiologyAnti-inflammatoryMedicinePhysiologyCalcium/camkii/murf-1 AxisPharmacotherapyAkr1b1 InhibitionCardiovascular ToxicityPharmacologyOxidative Stress
| Year | Citations | |
|---|---|---|
Page 1
Page 1